Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS). - Llamas-Velasco M; Hospital M; López-Ferrer A; Herranz P; Ruíz-Villaverde R; Mateu A; García-Latasa FJ; Rivera R; Fernández-Freire LR; Alcazar ED; Santos S; Arias S; et al. (Pharmacy (Basel), 2026)